INFORMED.
LIVE

Orchid Pharma Limited

BSE: ORCHPHARMA524372ISIN INE191A01027
  • Healthcare
  • Pharmaceuticals
  • BSE 1000

Share price

₹989.10+32.90 (+3.44%)
as of 18 Sep 2026
Orchid Pharma Limited share price, 18 Sep 2025 to 18 Sep 2026: ₹716.90 to ₹989.10 (+38.0%). Low ₹503.45, high ₹1,099.65. Volume shown below the price.
52W high
₹1,130.00
52W low
₹471.30
Off 52W high
-12.47%
1M return
+0.94%
3M return
+0.73%
6M return
+84.40%
1Y return
+37.97%
20D avg volume
5,007
50 DMA
₹1,000.14
200 DMA
₹791.40

Key ratios Consolidated

Market cap
₹5,017 Cr
Current price
₹989.10
52W high / low
₹1,130.00 / ₹471.30
Face value
₹10.00
P/E
467.75
P/B
EPS (TTM)
₹2.11
Book value / share
ROE
ROCE
2.10%
Operating margin
Net margin
Debt / equity
0.28
Net debt
₹350.47 Cr
Interest cover
2.59
Dividend yield
Dividend / share (TTM)
Payout
Cash conversion cycle
130.7 days

Financials

MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q4 FY24
Income statement
304.17237.61207.27193.52172.93237.48
1.837.345.6110.7711.453.90
303.35222.70217.91207.63170.67222.28
206.42120.95118.97112.27110.16136.94
0.610.480.250.170.791.24
28.0420.8824.1324.8521.6122.24
2.233.093.183.733.263.92
10.958.879.038.908.658.87
57.8338.5138.4337.6438.2849.24
2.6522.25-5.03-3.3313.7119.09
0.000.54-7.110.000.000.00
2.6522.79-12.15-3.3313.7119.09
0.070.000.000.000.00-0.04
3.2223.78-12.61-5.7214.9122.29
0.544.69-2.49-1.132.944.40
Key metrics
15.8334.750.069.3025.6231.88
5.20%14.60%0.00%4.80%14.80%13.40%
1.10%10.00%-6.10%-3.00%8.60%9.40%
1.60%0.00%1.60%
75.90%0.10%
-78.40%6.70%
MetricTTMFY26FY25FY24
Income statement
942.57811.33921.93
25.5535.1727.47
951.59818.91853.84
558.61462.34585.46
1.511.692.61
97.9091.4786.36
12.2313.2614.54
37.7535.4534.55
172.41152.85174.17
16.5427.5995.56
-6.57-6.570.00
9.9621.0295.56
0.07-0.19-0.19
8.6720.5599.66
1.614.0519.65
Key metrics
59.9469.73144.65
6.36%8.60%15.70%
0.92%2.50%10.80%
2.10%7.90%
-12.00%
-79.40%
-282.38-130.89
4.920.19
0.280.14
350.47153.13
130.7137.0
Balance sheet
1,9111,688
683.61807.42
7.0121.11
263.87241.83
256.41326.37
76.6753.76
613.22631.59
229.90222.09
278.97285.57
357.48174.24
29.7542.60
327.73131.64
1,2881,267
Cash flow
101.2019.22
-285.27-26.93
169.9825.22
383.58150.11
MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q4 FY24
Income statement
304.17237.61207.27193.52172.93237.48
10.0513.3010.5915.4315.936.26
302.28220.84216.57206.72170.66215.89
206.42120.95118.97112.27110.16136.94
0.610.480.250.170.791.24
26.7619.5922.8824.0521.6122.24
2.213.083.173.733.263.98
10.909.158.978.798.658.76
58.1137.6638.4037.6438.2742.89
11.9430.061.292.2318.2027.85
0.000.54-7.110.000.000.00
11.9430.60-5.822.2318.2027.85
0.000.000.000.000.000.00
11.9430.60-5.822.2318.2027.85
1.996.03-1.150.443.595.49
Key metrics
25.0542.836.3214.7530.1140.59
8.20%18.00%3.00%7.60%17.40%17.10%
3.90%12.90%-2.80%1.20%10.50%11.70%
2.10%0.40%2.20%
75.90%0.10%
-34.40%9.90%
MetricTTMFY26FY25FY24
Income statement
942.57811.33921.93
49.3755.2431.93
946.41814.79847.37
558.61462.34585.46
1.511.692.61
93.2888.1486.36
12.1913.2414.54
37.8135.5634.44
171.81151.98167.81
45.5251.78106.48
-6.57-6.570.00
38.9545.21106.48
0.000.000.00
38.9545.21106.48
7.318.9120.99
Key metrics
88.9594.01155.46
9.44%11.60%16.90%
4.13%5.60%11.50%
3.70%8.30%
-12.00%
-57.50%
-47.13-41.06
2.620.26
0.130.13
178.34158.37
162.3157.4
Balance sheet
1,7501,697
635.99786.39
1.2415.87
263.87241.83
256.41326.37
46.3748.45
591.69612.12
159.57170.48
182.80237.47
179.58174.24
0.9642.60
178.62131.64
1,3701,324
Cash flow
118.6427.48
-125.37-37.35
-7.9025.44
165.7768.54

Compounded growth

Standalone

Sales CAGR 3Y
Sales CAGR 5Y
Sales CAGR 10Y
Profit CAGR 3Y
Profit CAGR 5Y
Profit CAGR 10Y
Sales YoY (TTM)
Profit YoY (TTM)

Consolidated

Sales CAGR 3Y
Sales CAGR 5Y
Sales CAGR 10Y
Profit CAGR 3Y
Profit CAGR 5Y
Profit CAGR 10Y
Sales YoY (TTM)
Profit YoY (TTM)

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding
69.84%
HolderTypeHoldingPreviousChange
Dhanuka Laboratories LimitedPromoter69.84%
QUANT MUTUAL FUND - QUANT SMALL CAP FUNDPublic6.83%
KOTAK MAHINDRA TRUSTEE CO LTD A/C KOTAK CONSUMPTION FUND AND 7 OTHERSPublic4.60%
UTI SMALL CAP FUND AND 3 OTHERSPublic3.46%
INVESCO INDIA CONTRA FUND AND 2 OTHERSPublic2.87%
BANDHAN SMALL CAP FUND AND 5 OTHERSPublic1.53%
Stock BrokersPublic0.00%
MIMI AGARWALLAPublic0.00%

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

Board meetings

  • Board Meeting - Financial Results